Principal Investigator: Mukta Arora

MT2016-04 :Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma with or without Vaccination of Dendritic Cell/Myeloma Fusions (CTN 1401)